Personalized_Medicine_A_New_Medical_and_Social_Challenge

Table 1 (continued)

Ovarian Hays JL, Kim G, Giuroiu I, Kohn E, C (2010) Proteomics and

ovarian cancer: Integrating proteomics information into clinical

care. J Proteomics 73:1864–1872

Leung F, Musrap N, Diamandis EP, Kulasingam V (2013)

Advances in mass spectrometry-based technologies to direct per-

sonalized medicine in ovarian cancer. Translational Proteomics

1:74–86

Sereni MI et al. (2014) Functional Characterization of Epithelial

Ovarian Cancer Histotypes by Drug Target-Based Protein Signal-

ing Activation Mapping: Implications for Personalized Cancer

Therapy. Proteomics doi:10.1002/pmic.201400214

Pancreatic Kim MS et al. (2014) Heterogeneity of Pancreatic Cancer Metas-

tases in a Single Patient Revealed by Quantitative Proteomics. Mol

Cell Proteomics 13:2803–2811

Urological and

prostate

Fredolini C, Liotta LA, Petricoin EF (2010) Application of prote-

omic technologies for prostate cancer detection, prognosis, and

tailored therapy. Crit Rev Clin Lab Sci 47:125–138

Schiffer E (2011) Urinary proteomics: ready for prime time in

urological cancer diagnostics? Personalized Medicine 8(1):81–94

Sarcoma and

melanoma

Kondo T, Suehara Y, Kikuta K, Kubota D, Tajima T, Mukaihara K,

Ichikawa H, Kawai A (2013) Proteomic approach toward person-

alized sarcoma treatment: Lessons from prognostic biomarker

discovery in gastrointestinal stromal tumor. Proteomics Clinical

Applications 7:70–78

Sugihara Y et al. (2014) A new look at drugs targeting malignant

melanoma—An application for mass spectrometry imaging. Pro-

teomics 14:1963–1970

Chronic degenerative

disease

Licastro F, Caruso C (2010) Predictive diagnostics and personal-

ized medicine for the prevention of chronic degenerative diseases.

Licastro and Caruso Immunity & Ageing 7:http://www.

immunityageing.com/content/7/S1/S1

Diabetes mellitus Glauber HS, Rishe N, Karnieli E (2014) Introduction to Personal-

ized Medicine in Diabetes Mellitus. Rambam Maimonides Medical

Journal 5 (1):e0002. Doi:10.5041/RMMJ.10136

Liver fibrosis and cirrhosis Shammel Baker S et al. (2014) Advancing the High Throughput

Identification of Liver Fibrosis Protein Signatures Using

Multiplexed Ion Mobility Spectrometry. Mol Cell Proteomics

13:1119–1127

Faouder J, Laouirem S, Chapelle M, Albuquerque M, Belghiti J,

Degos F, Paradis V, Camadro JM, Bedossa P (2011) Imaging Mass

Spectrometry Provides Fingerprints for Distinguishing Hepatocel-

lular Carcinoma from Cirrhosis. J Proteome Res 10:3755–3765

Neurodegenerative

disease

Goldknopf IL (2008) Blood-based proteomics for personalized

medicine: examples from neurodegenerative disease. Expert

Reviews of Proteomics 5(1):1–8

Pulmonary hypertension Colvin KL, Yeager ME (2014) Proteomics of pulmonary hyper-

tension: could personalized profiles lead to personalized medicine?

Proteomics Clinical Applications doi:10.1002/prca.201400157

(continued)

196 D. Josic ́and U. Andjelkovic ́